BioLife Solutions BLFS 深 沪
已收盘 08-15 16:00:00 美东时间
24.34
-0.980
-3.87%
华盛通- 最 高25.7799
- 今 开25.46
- 成交量 130.01万股
- 最 低 24.05
- 昨 收 25.32
- 总市值 11.58亿
- 52周最高 29.545
- 市盈率 静 --
- 换手率 2.73%
- 52周最低 19.10
- 委 比 61.59%
- 总股本 4756.12万
- 历史最高 60.669
- 量 比 1.48
- 振 幅 6.83%
- 历史最低 0.02
- 每 手 1
- 风险率 2.09%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多HC Wainwright & Co. Maintains Buy on BioLife Solutions, Raises Price Target to $32
HC Wainwright & Co. analyst Yi Chen maintains BioLife Solutions (NASDAQ:BLFS) with a Buy and raises the price target from $30 to $32.
08-08 18:38
BioLife Solutions Raises FY2025 Sales Guidance from $95.500M-$99.000M to $100.000M-$103.000M vs $97.747M Est
BioLife Solutions (NASDAQ:BLFS) raises FY2025 sales outlook from $95.500 million-$99.000 million to $100.000 million-$103.000 million vs $97.747 million estimate.
08-08 04:13
Here are the major earnings after the close Thursday
Major earnings expected after the bell on Thursday include: Block (XYZ) Gilead Sciences (GILD) Twilio (TWLO) The Trade Desk (TTD) Main Street Capital Corporation (MAIN) Other earnings slated for rele...
08-07 22:00
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
Examining the Future: Niagen Bioscience's Earnings Outlook
Niagen Bioscience (NASDAQ:NAGE) is preparing to release its quarterly earnings ...
08-06 02:04
BioLife Solutions Announces $2M Investment In Pluristyx
BioLife Solutions, Inc. (NASDAQ:BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced that as part of a larger round of
07-28 20:07
新浪财经ESG：BioLife Solutions Inc. MSCI（明晟）ESG评级调升至A
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
06-28 07:00
美股大行评级 | 潜在涨幅158.9%！蒙特利尔银行上调Disc Medicine目标价至120美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1129333511617925121.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 蒙特利尔银行：维持Disc Medicine(IRON)"跑赢大市"评级，目标价从112美元升至120美元</p> <p>• 巴克莱：维持Karyopharm Therapeutics(KPTI)"超配"评级，目标价从5美
05-14 08:48
HC Wainwright & Co. Reiterates Buy on BioLife Solutions, Maintains $30 Price Target
HC Wainwright & Co. analyst Yi Chen reiterates BioLife Solutions (NASDAQ:BLFS) with a Buy and maintains $30 price target.
05-13 20:03
BioLife Solutions Reports Strong Start to 2025
BioLife Solutions Inc ( ($BLFS) ) has released its Q1 earnings. Here is a break...
05-09 12:59
